Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer
{{output}}
Purpose: De novo metastatic breast cancer (dnMBC), defined as stage IV disease at initial diagnosis, comprises 6-10% of all metastatic breast cancer cases. Despite therapeutic advances, the unique clinical course of dnMBC remains... ...
